Vasopressin (long grove) 1 u
Products billed under this code include Vasopressin.
Payment limit per 1 UNIT, by effective quarter, 1Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Vasopressin.
Payment limit per 1 UNIT, by effective quarter, 1Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Vasopressin | Long Grove Pharmaceuticals, LLC | 81298-8552-03 | 200 | $342.40 |
| Vasopressin | Long Grove Pharmaceuticals, LLC | 81298-8554-03 | 400 | $684.80 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.712 | +$0.578 | 1 UNIT | Vasopressin (long grove) 1 u | v1, posted September 17, 2026 |
| 3Q26 | $1.134 | −$0.05 | 1 UNIT | Vasopressin (long grove) 1 u | v1, posted September 15, 2026 |
| 2Q26 | $1.184 | −$0.606 | 1 UNIT | Vasopressin (long grove) 1 u | v1, posted September 15, 2026 |
| 1Q26 | $1.79 | – | 1 UNIT | Vasopressin (long grove) 1 u | v1, posted September 15, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.